Location History:
- Tinton Falls, NJ (US) (2011 - 2023)
- Edison, NJ (US) (2017 - 2024)
Company Filing History:
6 out of 9 
4 out of 66 
2 out of 24 
Years Active: 2011-2024
Title: The Innovative Contributions of William J. Polvino
Introduction
William J. Polvino is a notable inventor based in Edison, NJ, with a remarkable portfolio of 15 patents. His work primarily focuses on medical treatments and organ transplant methodologies, showcasing his commitment to advancing healthcare solutions.
Latest Patents
One of his latest patents is titled "Regimen for Suppressing Organ Rejection." This invention relates to a method of suppressing organ rejection in patients receiving organ transplants. It involves initiating oral treatment with a once-daily extended release tacrolimus dosage form, which is administered at an initial dose of approximately 0.15 to 0.20 mg/kg/day within 24 or 48 hours following transplantation. This innovative dosage form provides low fluctuation of tacrolimus levels, significantly lower concentrations than immediate release formulations while maintaining the same or greater area under the curve (AUC). Additionally, it releases tacrolimus primarily in the colon and/or lower ileum, ensuring effective treatment.
Another significant patent involves "Medical Treatments Based on Anamorelin." This patent describes methods for treating cancer-related conditions using anamorelin, further emphasizing Polvino's dedication to improving patient outcomes through innovative medical solutions.
Career Highlights
Throughout his career, William J. Polvino has made substantial contributions to the field of medicine. He has worked with prominent companies such as Helsinn Therapeutics (U.S.), Inc. and Helsinn Healthcare S.A., where he has played a crucial role in developing groundbreaking medical treatments.
Collaborations
Polvino has collaborated with esteemed colleagues, including William Mann and John Friend, to further enhance the impact of his inventions in the medical field.
Conclusion
William J. Polvino's innovative contributions to medical science, particularly in organ transplant and cancer treatment, highlight his significant role as an inventor. His patents reflect a commitment to improving patient care and advancing medical technology.